FIELD: pharmaceutics. SUBSTANCE: pharmaceutical composition of delayed secretion is indicated for treating psychotic states or hyperactivity in warm-blooded animals. The composition in question includes either 11-[4-[2-(2-hydroxyethoxy)ethyl]-1- piperazinyl]dibenzo[b,f][1,4]thiazepine or its pharmaceutically acceptable fillers and hydroxypropylmethylcellulose as a gel-forming agent. Delayed secretion provides similar and constant rate of secretion for prolonged period of time. Stable and desired level of active ingredient is achieved in blood plasma without any necessity for frequent intake of remedies. EFFECT: higher efficiency of therapy. 14 cl, 2 dwg, 12 ex, 12 tbl
| Title |
Year |
Author |
Number |
| CRYSTALLINE DERIVATIVE OF DIBENZOTHIAZEPINE, METHOD FOR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1998 |
|
RU2224754C2 |
| QUINAZOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND A METHOD FOR REACHING ANTIPROLIFERATIVE EFFECTS |
1996 |
|
RU2153495C2 |
| QUETIAPINE GRANULATED COMPOSITION |
2000 |
|
RU2256453C2 |
| PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, PHYSICAL FORM OF N-;4-;5-(CYCLOPENTYLOXYCARBONYL)AMINO-1-METHILINDOL-3-IL-METHYL-3- -METHOXYBENZOIL |
1991 |
- Dzhejms Dzhozef Kholokhan[Gb]
- Ieuan Dzhon Ehdvrds[Gb]
- Robert Dzhozef Timko[Us]
- Rehndi Dzhon Brehdvehj[Us]
- Arlin Klements[Us]
|
RU2106140C1 |
| DERIVATIVES OF QUINAZOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON SAID |
1993 |
|
RU2127263C1 |
| TABLET QUETIAPINE WITH PROLONGED RELEASE AND SYNTHESIS METHOD THEREOF |
2015 |
- Syrov Kirill Konstantinovich
- Nesteruk Vladimir Viktorovich
|
RU2588840C1 |
| PIPERIDINYL-SUBSTITUTED METHANOANTHRACENES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A PHARMACEUTICAL COMPOSITION BASED ON SAID AND METHODS OF THEIR SYNTHESIS |
1994 |
- Majkl Taddeus Klimas
- Mark Ornal Terpko
|
RU2128178C1 |
| PHARMACEUTICAL COMPOSITION, METHOD OF HEPIRON ADMINISTRATION, ORAL MEDICINAL FORM |
1995 |
- Stefen T. Dehvid
- Klod E. Gal'Jan
- Dzhozef S.Kh. Chou
|
RU2155044C2 |
| CRYSTALLINE FORM OF N-[4-[5(CYCLOPENTYLOXYCARBONYL)-AMINO-1-METHYL-INDOLE-3-YLMETHYL]-3- METHOXYBENZOYL]-2-METHYLBENZENE SULFONE AMIDE POSSESSING ACTIVITY AS ANTAGONIST OF LEUCOTRIENES |
1991 |
- Martin Pol Ehdvards[Gb]
- Dzhon Dehvid Shervud[Gb]
|
RU2107682C1 |
| METHOD FOR PREPARING QUETIAPINE AND INTERMEDIATE COMPOUNDS |
2001 |
- Bozhing Daniehl'
- Kovan'Ine Laks D'Erd'I
- Shimig D'Jula
- Rakotsi D'Erd'Ne
- Tempe Peter
- Krasnai D'Erd'
- Veretskejne Donat D'Erd'I
- Nad' Kal'Man
|
RU2258067C2 |
